Antikor (United Kingdom)

Recent papers from Antikor (United Kingdom)

1. Abstract 4399: ANT045: A novel format, antibody fragment drug-conjugate (FDC) product for challenging cMET-expressing solid tumorsCancer Research · 2026
2. Abstract 2408: ADCs in cancer treatment: SPR-driven insights into discovery and characterization.Cancer Research · 2026
3. Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCsMolecular Cancer Therapeutics · 2025
4. Age‐specific and compartment‐dependent changes in mitochondrial homeostasis and cytoplasmic viscosity in mouse peripheral neuronsAging Cell · 2024
5. Fluorescence lifetime imaging microscopy of flexible and rigid dyes probes the biophysical properties of synthetic and biological membranesBiophysical Journal · 2024
6. Age-specific and compartment-dependent changes in mitochondrial homeostasis and cytoplasmic viscosity in mouse peripheral neurons2023
7. Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice2022
8. Current strategies for the discovery and bioconjugation of smaller, targetable drug conjugates tailored for solid tumor therapyExpert Opinion on Drug Discovery · 2020
9. Tackling solid tumour therapy with small-format drug conjugatesAntibody Therapeutics · 2020
10. Time‐Resolved Fluorescence Anisotropy of a Molecular Rotor Resolves Microscopic Viscosity Parameters in Complex EnvironmentsSmall · 2020
11. A Single Synonymous Variant (c.354G>A [p.P118P]) in ADAMTS13 Confers Enhanced Specific ActivityInternational Journal of Molecular Sciences · 2019
12. Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and ApplicationsChemMedChem · 2018
13. Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expressionOncotarget · 2018
14. Small-Format Drug Conjugates: A Viable Alternative to ADCs for Solid Tumours?Antibodies · 2018
15. Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?Prenatal Diagnosis · 2017
16. Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugateOncotarget · 2017
17. Emerging formats for next-generation antibody drug conjugatesExpert Opinion on Drug Discovery · 2015
18. Immunotherapy Responsive Epilepsies: General Clinical Features, Commonly Detected Antibodies and Treatment StudiesJournal of the Turkish Epilepsi Society · 2015